Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context

Cancer Cell

Volumn 4, Issue 2, 2003, Pages 111-120

  Guerra, Carmen ^a   Mijimolle, Nieves ^a   Dhawahir, Alma ^a   Dubus, Pierre ^b   Barradas, Marta ^a,c   Serrano, Manuel ^a,c   Campuzano, Victoria ^a   Barbacid, Mariano ^a  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE;

ADENOCARCINOMA; ADENOMA; ALLELE; ANIMAL CELL; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL FATE; CELL GROWTH; CELL IMMORTALIZATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; FIBROBLAST; GENE CASSETTE; HEMATOPOIETIC CELL; LUNG ALVEOLUS CELL CARCINOMA; MALIGNANT TRANSFORMATION; MARKER GENE; MOUSE; NONHUMAN; ONCOGENE K RAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENESCENCE; TARGET CELL;

ANIMALIA;

EID: 0041883654     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1535-6108(03)00191-0     Document Type: Article

References (33)

1. Agell N., Bachs O., Rocamora N., Villalonga P. Modulation of the Ras/Raf/MEK/ERK pathway by Ca(2+), and calmodulin. Cell. Signal. 14:2002;649-654.
2. Almoguera C., Shibata D., Forrester K., Martin J., Arnheim N., Perucho M. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell. 53:1988;549-554.
3. Balmanno K., Cook S.J. Sustained MAP kinase activation is required for the expression of cyclin D1, p21Cip1 and a subset of AP-1 proteins in CCL39 cells. Oncogene. 18:1999;3085-3097.
4. Barradas M., Gonos E.S., Zebedee Z., Kolettas E., Petropoulou C., Delgado M.D., Leon J., Hara E., Serrano M. Identification of a candidate tumor-suppressor gene specifically activated during Ras-induced senescence. Exp. Cell Res. 273:2002;127-137.
5. Bos J.L. ras oncogenes in human cancer. a review Cancer Res. 49:1989;4682-4689.
6. Brocard J., Warot X., Wendling O., Messaddeq N., Vonesch J.L., Chambon P., Metzger D. Spatio-temporally controlled site-specific somatic mutagenesis in the mouse. Proc. Natl. Acad. Sci. USA. 94:1997;14559-14563.
7. Cowley S., Paterson H., Kemp P., Marshall C.J. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell. 77:1994;841-852.
8. Chen J., Baithun S.I., Ramsay M.A. Histogenesis of pancreatic carcinomas. a study based on 248 cases J. Pathol. 146:1985;65-76.
9. Downward J. Targeting Ras signalling pathways in cancer therapy. Nat. Rev. Cancer. 3:2003;11-22.
10. Fisher G.H., Wellen S.L., Klimstra D., Lenczowski J.M., Tichelaar J.W., Lizak M.J., Whitsett J.A., Koretsky A., Varmus H.E. Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. Genes Dev. 15:2001;3249-3262.
11. Friedrich G., Soriano P. Promoter traps in embryonic stem cells. a genetic screen to identify and mutate developmental genes in mice Genes Dev. 5:1991;1513-1523.
12. Hogan B., Beddington R., Costantini F., Lacy E. Manipulating the Mouse Embryo. A Laboratory Manual Second edition:1994;Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
13. Jackson E.L., Willis N., Mercer K., Bronson R.T., Crowley D., Montoya R., Jacks T., Tuveson D.A. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev. 15:2001;3243-3248.
14. Johnson L., Greenbaum D., Cichowski K., Mercer K., Murphy E., Schmitt E., Bronson R.T., Umanoff H., Edelmann W., Kucherlapati R., Jacks T. K-ras is an essential gene in the mouse with partial functional overlap with N-ras. Genes Dev. 11:1997;2468-2481.
15. Johnson L., Mercer K., Greenbaum D., Bronson R.T., Crowley D., Tuveson D.A., Jacks T. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature. 410:2001;1111-1116.
16. Kraus V.B., Moran E., Nevins J.R. Promoter-specific trans-activation by the adenovirus E1A12S product involves separate E1A domains. Mol. Cell. Biol. 12:1992;4391-4399.
17. Lakso M., Sauer B., Mosinger B. Jr., Lee E.J., Manning R.W., Yu S.H., Mulder K.L., Westphal H. Targeted oncogene activation by site-specific recombination in transgenic mice. Proc. Natl. Acad. Sci. USA. 89:1992;6232-6236.
18. Leon J., Guerrero I., Pellicer A. Differential expression of the ras gene family in mice. Mol. Cell. Biol. 7:1987;1535-1540.
19. Loonstra A., Vooijs M., Beverloo H.B., Allak B.A., van Drunen E., Kanaar R., Berns A., Jonkers J. Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells. Proc. Natl. Acad. Sci. USA. 98:2001;9209-9214.
20. Marshall C.J. Specificity of receptor tyrosine kinase signaling. transient versus sustained extracellular signal-regulated kinase activation Cell. 80:1995;179-185.
21. Meuwissen R., Linn S.C., van der Valk M., Mooi W.J., Berns A. Mouse model for lung tumorigenesis through Cre/lox controlled sporadic activation of the K-Ras oncogene. Oncogene. 20:2001;6551-6558.
22. Mountford P., Zevnik B., Duwel A., Nichols J., Li M., Dani C., Robertson M., Chambers I., Smith A. Dicistronic targeting constructs. reporters and modifiers of mammalian gene expression Proc. Natl. Acad. Sci. USA. 91:1994;4303-4307.
23. Nagy A., Rossant J., Nagy R., Abramow-Newerly W., Roder J.C. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc. Natl. Acad. Sci. USA. 90:1993;8424-8428.
24. Oudejans J.J., Slebos R.J., Zoetmulder F.A., Mooi W.J., Rodenhuis S. Differential activation of ras genes by point mutation in human colon cancer with metastases to either lung or liver. Int. J. Cancer. 49:1991;875-879.
25. Plovins A., Alvarez A.M., Ibañez M., Molina M., Nombela C. Use of fluorescein-di-beta-D-galactopyranoside (FDG) and C12-FDG as substrates for beta-galactosidase detection by flow cytometry in animal, bacterial, and yeast cells. Appl. Environ. Microbiol. 60:1994;4638-4641.
26. Ruley H.E. Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture. Nature. 304:1983;602-606.
27. Schwenk F., Baron U., Rajewsky K. A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res. 23:1995;5080-5081.
28. Serrano M., Lin A.W., McCurrach M.E., Beach D., Lowe S.W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell. 88:1997;593-602.
29. Sotillo R., Dubus P., Martin J., de la Cueva E., Ortega S., Malumbres M., Barbacid M. Wide spectrum of tumors in knock-in mice carrying a Cdk4 protein insensitive to INK4 inhibitors. EMBO J. 20:2001;6637-6647.
30. Todaro G.J., Green H. Quantitative studies of the growth of mouse embryo cells in culture and their development into stablish lines. J. Cell Biol. 17:1963;299-313.
31. Vetter I.R., Wittinghofer A. The guanine nucleotide-binding switch in three dimensions. Science. 294:2001;1299-1304.
32. Yanagisawa A., Ohtake K., Ohashi K., Hori M., Kitagawa T., Sugano H., Kato Y. Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation. Cancer Res. 53:1993;953-956.
33. Zhang Z., Wang Y., Vikis H.G., Johnson L., Liu G., Li J., Anderson M.W., Sills R.C., Hong H.L., Devereux T.R.et al. Wildtype Kras2 can inhibit lung carcinogenesis in mice. Nat. Med. 29:2001;25-33.